KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Finished Goods (2022 - 2025)

Historic Finished Goods for Opko Health (OPK) over the last 4 years, with Q3 2025 value amounting to $42.3 million.

  • Opko Health's Finished Goods rose 2353.1% to $42.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.3 million, marking a year-over-year increase of 2353.1%. This contributed to the annual value of $32.3 million for FY2024, which is 919.57% down from last year.
  • Opko Health's Finished Goods amounted to $42.3 million in Q3 2025, which was up 2353.1% from $42.2 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Finished Goods ranged from a high of $42.3 million in Q3 2025 and a low of $32.3 million during Q4 2024
  • Moreover, its 4-year median value for Finished Goods was $35.6 million (2023), whereas its average is $36.7 million.
  • Per our database at Business Quant, Opko Health's Finished Goods plummeted by 919.57% in 2024 and then surged by 2353.1% in 2025.
  • Quarter analysis of 4 years shows Opko Health's Finished Goods stood at $37.1 million in 2022, then dropped by 4.19% to $35.6 million in 2023, then fell by 9.2% to $32.3 million in 2024, then surged by 30.78% to $42.3 million in 2025.
  • Its last three reported values are $42.3 million in Q3 2025, $42.2 million for Q2 2025, and $39.9 million during Q1 2025.